Company Performance Metrics
Spun out of GlaxoSmithKline Pharmaceuticals (GSK) in 2010, Transpharmation was created to be a CRO with a difference; cross therapeutic area expertise in translational pharmacology from bench to bedside.
With headquarters based in central London, England and laboratories just north of the Captial, Transpharmation is rapidly growing and bucking
the trend in the languishing CRO market since the financial crisis in 2007/2008.
Transpharmation is led by a team with years of proven hands-on drug discovery and business expertise. This has allowed us to build client and science-focused relationships, across their extensive network in the pharmaceutical and biotechnology sectors.
Their mission is simple; they wish to be known as the market leader in the provision of innovation and science-led translational biology. They believe, they have made significant steps to achieving this goal and invite you to explore their website to further understand how their strategy can enhance your Drug Discovery programmes.
